SHIP1_HUMAN - dbPTM
SHIP1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SHIP1_HUMAN
UniProt AC Q92835
Protein Name Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1
Gene Name INPP5D
Organism Homo sapiens (Human).
Sequence Length 1189
Subcellular Localization Cytoplasm . Cell membrane
Peripheral membrane protein . Membrane raft . Cytoplasm, cytoskeleton . Membrane
Peripheral membrane protein . Translocates to the plasma membrane when activated, translocation is probably due to different mechanisms dep
Protein Description Phosphatidylinositol (PtdIns) phosphatase that specifically hydrolyzes the 5-phosphate of phosphatidylinositol-3,4,5-trisphosphate (PtdIns(3,4,5)P3) to produce PtdIns(3,4)P2, thereby negatively regulating the PI3K (phosphoinositide 3-kinase) pathways. Acts as a negative regulator of B-cell antigen receptor signaling. Mediates signaling from the FC-gamma-RIIB receptor (FCGR2B), playing a central role in terminating signal transduction from activating immune/hematopoietic cell receptor systems. Acts as a negative regulator of myeloid cell proliferation/survival and chemotaxis, mast cell degranulation, immune cells homeostasis, integrin alpha-IIb/beta-3 signaling in platelets and JNK signaling in B-cells. Regulates proliferation of osteoclast precursors, macrophage programming, phagocytosis and activation and is required for endotoxin tolerance. Involved in the control of cell-cell junctions, CD32a signaling in neutrophils and modulation of EGF-induced phospholipase C activity. Key regulator of neutrophil migration, by governing the formation of the leading edge and polarization required for chemotaxis. Modulates FCGR3/CD16-mediated cytotoxicity in NK cells. Mediates the activin/TGF-beta-induced apoptosis through its Smad-dependent expression. May also hydrolyze PtdIns(1,3,4,5)P4, and could thus affect the levels of the higher inositol polyphosphates like InsP6..
Protein Sequence MVPCWNHGNITRSKAEELLSRTGKDGSFLVRASESISRAYALCVLYRNCVYTYRILPNEDDKFTVQASEGVSMRFFTKLDQLIEFYKKENMGLVTHLQYPVPLEEEDTGDDPEEDTVESVVSPPELPPRNIPLTASSCEAKEVPFSNENPRATETSRPSLSETLFQRLQSMDTSGLPEEHLKAIQDYLSTQLAQDSEFVKTGSSSLPHLKKLTTLLCKELYGEVIRTLPSLESLQRLFDQQLSPGLRPRPQVPGEANPINMVSKLSQLTSLLSSIEDKVKALLHEGPESPHRPSLIPPVTFEVKAESLGIPQKMQLKVDVESGKLIIKKSKDGSEDKFYSHKKILQLIKSQKFLNKLVILVETEKEKILRKEYVFADSKKREGFCQLLQQMKNKHSEQPEPDMITIFIGTWNMGNAPPPKKITSWFLSKGQGKTRDDSADYIPHDIYVIGTQEDPLSEKEWLEILKHSLQEITSVTFKTVAIHTLWNIRIVVLAKPEHENRISHICTDNVKTGIANTLGNKGAVGVSFMFNGTSLGFVNSHLTSGSEKKLRRNQNYMNILRFLALGDKKLSPFNITHRFTHLFWFGDLNYRVDLPTWEAETIIQKIKQQQYADLLSHDQLLTERREQKVFLHFEEEEITFAPTYRFERLTRDKYAYTKQKATGMKYNLPSWCDRVLWKSYPLVHVVCQSYGSTSDIMTSDHSPVFATFEAGVTSQFVSKNGPGTVDSQGQIEFLRCYATLKTKSQTKFYLEFHSSCLESFVKSQEGENEEGSEGELVVKFGETLPKLKPIISDPEYLLDQHILISIKSSDSDESYGEGCIALRLEATETQLPIYTPLTHHGELTGHFQGEIKLQTSQGKTREKLYDFVKTERDESSGPKTLKSLTSHDPMKQWEVTSRAPPCSGSSITEIINPNYMGVGPFGPPMPLHVKQTLSPDQQPTAWSYDQPPKDSPLGPCRGESPPTPPGQPPISPKKFLPSTANRGLPPRTQESRPSDLGKNAGDTLPQEDLPLTKPEMFENPLYGSLSSFPKPAPRKDQESPKMPRKEPPPCPEPGILSPSIVLTKAQEADRGEGPGKQVPAPRLRSFTCSSSAEGRAAGGDKSQGKPKTPVSSQAPVPAKRPIKPSRSEINQQTPPTPTPRPPLPVKSPAVLHLQHSKGRDYRDNTELPHHGKHRPEEGPPGPLGRTAMQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
11PhosphorylationCWNHGNITRSKAEEL
CCCCCCCCHHHHHHH
32.6528851738
14UbiquitinationHGNITRSKAEELLSR
CCCCCHHHHHHHHHH
57.4329967540
20PhosphorylationSKAEELLSRTGKDGS
HHHHHHHHHHCCCCC
40.1824719451
24UbiquitinationELLSRTGKDGSFLVR
HHHHHHCCCCCEEEE
59.30-
27PhosphorylationSRTGKDGSFLVRASE
HHHCCCCCEEEECCH
26.0728857561
33PhosphorylationGSFLVRASESISRAY
CCEEEECCHHHHHHH
22.7026699800
35PhosphorylationFLVRASESISRAYAL
EEEECCHHHHHHHHH
24.3026699800
40PhosphorylationSESISRAYALCVLYR
CHHHHHHHHHHHHHC
10.0522817900
46PhosphorylationAYALCVLYRNCVYTY
HHHHHHHHCCCEEEE
4.5620090780
78UbiquitinationVSMRFFTKLDQLIEF
CCHHHHHHHHHHHHH
44.93-
134PhosphorylationPPRNIPLTASSCEAK
CCCCCCCCCCCCEEE
21.0929978859
136PhosphorylationRNIPLTASSCEAKEV
CCCCCCCCCCEEEEC
30.2228348404
137PhosphorylationNIPLTASSCEAKEVP
CCCCCCCCCEEEECC
17.3229970186
141UbiquitinationTASSCEAKEVPFSNE
CCCCCEEEECCCCCC
36.63-
170PhosphorylationTLFQRLQSMDTSGLP
HHHHHHHCCCCCCCC
24.1828450419
173PhosphorylationQRLQSMDTSGLPEEH
HHHHCCCCCCCCHHH
18.9528450419
174PhosphorylationRLQSMDTSGLPEEHL
HHHCCCCCCCCHHHH
33.7828450419
182UbiquitinationGLPEEHLKAIQDYLS
CCCHHHHHHHHHHHH
45.40-
200UbiquitinationAQDSEFVKTGSSSLP
HCCCHHHHCCCCCCH
53.11-
203PhosphorylationSEFVKTGSSSLPHLK
CHHHHCCCCCCHHHH
23.2228270605
204PhosphorylationEFVKTGSSSLPHLKK
HHHHCCCCCCHHHHH
36.9228270605
205PhosphorylationFVKTGSSSLPHLKKL
HHHCCCCCCHHHHHH
47.8428270605
213PhosphorylationLPHLKKLTTLLCKEL
CHHHHHHHHHHHHHH
25.03-
221PhosphorylationTLLCKELYGEVIRTL
HHHHHHHHHHHHHHC
16.6028064214
227PhosphorylationLYGEVIRTLPSLESL
HHHHHHHHCCCHHHH
31.7130622161
230PhosphorylationEVIRTLPSLESLQRL
HHHHHCCCHHHHHHH
48.1330622161
233PhosphorylationRTLPSLESLQRLFDQ
HHCCCHHHHHHHHHC
34.7930622161
243PhosphorylationRLFDQQLSPGLRPRP
HHHHCCCCCCCCCCC
16.7523401153
243O-linked_GlycosylationRLFDQQLSPGLRPRP
HHHHCCCCCCCCCCC
16.7530059200
263PhosphorylationANPINMVSKLSQLTS
CCCHHHHHHHHHHHH
19.6723312004
274PhosphorylationQLTSLLSSIEDKVKA
HHHHHHHHHHHHHHH
29.93-
289PhosphorylationLLHEGPESPHRPSLI
HHCCCCCCCCCCCCC
29.1922115753
294PhosphorylationPESPHRPSLIPPVTF
CCCCCCCCCCCCEEE
38.6026307563
300PhosphorylationPSLIPPVTFEVKAES
CCCCCCEEEEEEHHH
21.6128857561
307PhosphorylationTFEVKAESLGIPQKM
EEEEEHHHCCCCCCE
36.4328060719
312UbiquitinationAESLGIPQKMQLKVD
HHHCCCCCCEEEEEE
52.5121890473
313UbiquitinationESLGIPQKMQLKVDV
HHCCCCCCEEEEEEE
24.2221890473
339PhosphorylationDGSEDKFYSHKKILQ
CCCCCCCCCHHHHHH
18.66-
364UbiquitinationLVILVETEKEKILRK
EEEEEECHHHHHHHC
45.7920972266
364 (in isoform 2)Ubiquitination-45.7921906983
365UbiquitinationVILVETEKEKILRKE
EEEEECHHHHHHHCH
72.2620972266
365AcetylationVILVETEKEKILRKE
EEEEECHHHHHHHCH
72.2621466224
371AcetylationEKEKILRKEYVFADS
HHHHHHHCHHEECCC
50.3719608861
373PhosphorylationEKILRKEYVFADSKK
HHHHHCHHEECCCHH
12.14-
423PhosphorylationAPPPKKITSWFLSKG
CCCCHHHEEEHHHCC
28.87-
424PhosphorylationPPPKKITSWFLSKGQ
CCCHHHEEEHHHCCC
21.2128555341
428PhosphorylationKITSWFLSKGQGKTR
HHEEEHHHCCCCCCC
25.8528555341
517PhosphorylationVKTGIANTLGNKGAV
CCCCHHHCCCCCCCE
27.3330108239
556PhosphorylationKLRRNQNYMNILRFL
HHHHCCCHHHHHHHH
5.04-
566 (in isoform 3)Ubiquitination-38.8021906983
607UbiquitinationETIIQKIKQQQYADL
HHHHHHHHHHHHHHH
49.44-
611PhosphorylationQKIKQQQYADLLSHD
HHHHHHHHHHHHCHH
9.57-
644PhosphorylationEITFAPTYRFERLTR
HEEECCCCCCEECCC
16.55-
656PhosphorylationLTRDKYAYTKQKATG
CCCCCCCCCCCCCCC
16.0428509920
657PhosphorylationTRDKYAYTKQKATGM
CCCCCCCCCCCCCCC
20.8728509920
699PhosphorylationSTSDIMTSDHSPVFA
CHHHCCCCCCCCCEE
18.88-
737PhosphorylationQIEFLRCYATLKTKS
HEEEEEEEEEEECCC
9.0022964224
739O-linked_GlycosylationEFLRCYATLKTKSQT
EEEEEEEEEECCCCC
11.4330059200
739PhosphorylationEFLRCYATLKTKSQT
EEEEEEEEEECCCCC
11.4322964224
744PhosphorylationYATLKTKSQTKFYLE
EEEEECCCCCEEEEE
48.6018077418
744O-linked_GlycosylationYATLKTKSQTKFYLE
EEEEECCCCCEEEEE
48.6030059200
754PhosphorylationKFYLEFHSSCLESFV
EEEEEEHHHHHHHHH
28.2418077418
755PhosphorylationFYLEFHSSCLESFVK
EEEEEHHHHHHHHHH
17.7218077418
763PhosphorylationCLESFVKSQEGENEE
HHHHHHHCCCCCCCC
28.3224719451
772PhosphorylationEGENEEGSEGELVVK
CCCCCCCCCCEEEEE
45.7923911959
778UbiquitinationGSEGELVVKFGETLP
CCCCEEEEEECCCCC
7.1330230243
778 (in isoform 2)Ubiquitination-7.1321906983
779UbiquitinationSEGELVVKFGETLPK
CCCEEEEEECCCCCC
39.922190698
779 (in isoform 1)Ubiquitination-39.9221906983
786UbiquitinationKFGETLPKLKPIISD
EECCCCCCCCCCCCC
72.72-
796PhosphorylationPIISDPEYLLDQHIL
CCCCCHHHHHCCEEE
20.2527259358
834PhosphorylationTETQLPIYTPLTHHG
ECCCCCEEECCCCCC
10.60-
835PhosphorylationETQLPIYTPLTHHGE
CCCCCEEECCCCCCE
16.73-
859UbiquitinationKLQTSQGKTREKLYD
EEECCCCCCHHHHHH
36.45-
863UbiquitinationSQGKTREKLYDFVKT
CCCCCHHHHHHHHHH
49.40-
865PhosphorylationGKTREKLYDFVKTER
CCCHHHHHHHHHHHC
20.5728674151
869UbiquitinationEKLYDFVKTERDESS
HHHHHHHHHHCCCCC
44.66-
879UbiquitinationRDESSGPKTLKSLTS
CCCCCCCCCHHHHCC
70.75-
880PhosphorylationDESSGPKTLKSLTSH
CCCCCCCCHHHHCCC
42.4229978859
882UbiquitinationSSGPKTLKSLTSHDP
CCCCCCHHHHCCCCH
48.96-
883PhosphorylationSGPKTLKSLTSHDPM
CCCCCHHHHCCCCHH
39.7428857561
885PhosphorylationPKTLKSLTSHDPMKQ
CCCHHHHCCCCHHHC
30.9823401153
886PhosphorylationKTLKSLTSHDPMKQW
CCHHHHCCCCHHHCE
31.0528450419
891UbiquitinationLTSHDPMKQWEVTSR
HCCCCHHHCEEEEEC
58.61-
908PhosphorylationPCSGSSITEIINPNY
CCCCCCHHEECCCCC
24.0727251275
915PhosphorylationTEIINPNYMGVGPFG
HEECCCCCCCCCCCC
9.1228674151
932PhosphorylationMPLHVKQTLSPDQQP
CCCEEEECCCCCCCC
24.4028450419
934PhosphorylationLHVKQTLSPDQQPTA
CEEEECCCCCCCCCC
29.8023401153
940PhosphorylationLSPDQQPTAWSYDQP
CCCCCCCCCCCCCCC
36.1028060719
943PhosphorylationDQQPTAWSYDQPPKD
CCCCCCCCCCCCCCC
19.1728060719
944PhosphorylationQQPTAWSYDQPPKDS
CCCCCCCCCCCCCCC
14.1128060719
951PhosphorylationYDQPPKDSPLGPCRG
CCCCCCCCCCCCCCC
28.3128450419
960PhosphorylationLGPCRGESPPTPPGQ
CCCCCCCCCCCCCCC
38.7223401153
963PhosphorylationCRGESPPTPPGQPPI
CCCCCCCCCCCCCCC
45.5623401153
971PhosphorylationPPGQPPISPKKFLPS
CCCCCCCCHHHCCCC
36.1223401153
974UbiquitinationQPPISPKKFLPSTAN
CCCCCHHHCCCCCCC
56.36-
978PhosphorylationSPKKFLPSTANRGLP
CHHHCCCCCCCCCCC
42.15-
979PhosphorylationPKKFLPSTANRGLPP
HHHCCCCCCCCCCCC
26.47-
988O-linked_GlycosylationNRGLPPRTQESRPSD
CCCCCCCCCCCCHHH
42.3230059200
991O-linked_GlycosylationLPPRTQESRPSDLGK
CCCCCCCCCHHHCCC
39.4130059200
994O-linked_GlycosylationRTQESRPSDLGKNAG
CCCCCCHHHCCCCCC
44.3430059200
1003PhosphorylationLGKNAGDTLPQEDLP
CCCCCCCCCCHHHCC
39.15-
1012PhosphorylationPQEDLPLTKPEMFEN
CHHHCCCCCHHHHCC
42.4829978859
1022PhosphorylationEMFENPLYGSLSSFP
HHHCCCCCCCHHCCC
13.1128674151
1024PhosphorylationFENPLYGSLSSFPKP
HCCCCCCCHHCCCCC
16.1227259358
1026PhosphorylationNPLYGSLSSFPKPAP
CCCCCCHHCCCCCCC
31.4629978859
1027PhosphorylationPLYGSLSSFPKPAPR
CCCCCHHCCCCCCCC
51.3529978859
1039PhosphorylationAPRKDQESPKMPRKE
CCCCCCCCCCCCCCC
24.9623401153
1045UbiquitinationESPKMPRKEPPPCPE
CCCCCCCCCCCCCCC
69.56-
1057PhosphorylationCPEPGILSPSIVLTK
CCCCCCCCCEEEEEE
18.0623401153
1059PhosphorylationEPGILSPSIVLTKAQ
CCCCCCCEEEEEEHH
23.1928450419
1063PhosphorylationLSPSIVLTKAQEADR
CCCEEEEEEHHHCCC
17.2829978859
1076UbiquitinationDRGEGPGKQVPAPRL
CCCCCCCCCCCCCCC
51.78-
1085PhosphorylationVPAPRLRSFTCSSSA
CCCCCCCEEEECCCC
29.5123401153
1087PhosphorylationAPRLRSFTCSSSAEG
CCCCCEEEECCCCCC
16.8428857561
1089PhosphorylationRLRSFTCSSSAEGRA
CCCEEEECCCCCCCC
25.0324719451
1090PhosphorylationLRSFTCSSSAEGRAA
CCEEEECCCCCCCCC
35.4028348404
1091PhosphorylationRSFTCSSSAEGRAAG
CEEEECCCCCCCCCC
17.6628348404
1102PhosphorylationRAAGGDKSQGKPKTP
CCCCCCCCCCCCCCC
49.2423312004
1107UbiquitinationDKSQGKPKTPVSSQA
CCCCCCCCCCCCCCC
69.79-
1108PhosphorylationKSQGKPKTPVSSQAP
CCCCCCCCCCCCCCC
37.1323401153
1111PhosphorylationGKPKTPVSSQAPVPA
CCCCCCCCCCCCCCC
20.2423312004
1112PhosphorylationKPKTPVSSQAPVPAK
CCCCCCCCCCCCCCC
30.5123312004
1119UbiquitinationSQAPVPAKRPIKPSR
CCCCCCCCCCCCCCH
53.27-
1123UbiquitinationVPAKRPIKPSRSEIN
CCCCCCCCCCHHHHH
39.36-
1127PhosphorylationRPIKPSRSEINQQTP
CCCCCCHHHHHCCCC
47.3629052541
1133PhosphorylationRSEINQQTPPTPTPR
HHHHHCCCCCCCCCC
22.8228450419
1136PhosphorylationINQQTPPTPTPRPPL
HHCCCCCCCCCCCCC
40.7828450419
1138PhosphorylationQQTPPTPTPRPPLPV
CCCCCCCCCCCCCCC
34.1129052541
1140MethylationTPPTPTPRPPLPVKS
CCCCCCCCCCCCCCC
48.20115387943
1147PhosphorylationRPPLPVKSPAVLHLQ
CCCCCCCCCCEEEEE
20.5123403867
1156PhosphorylationAVLHLQHSKGRDYRD
CEEEEECCCCCCCCC
24.6823403867
1157UbiquitinationVLHLQHSKGRDYRDN
EEEEECCCCCCCCCC
56.70-
1161PhosphorylationQHSKGRDYRDNTELP
ECCCCCCCCCCCCCC
20.6429978859
1165PhosphorylationGRDYRDNTELPHHGK
CCCCCCCCCCCCCCC
43.0929978859
1172UbiquitinationTELPHHGKHRPEEGP
CCCCCCCCCCCCCCC
31.89-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of SHIP1_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SHIP1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SHIP1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
DOK1_HUMANDOK1physical
10822173
DOK2_HUMANDOK2physical
10822173
SHC1_HUMANSHC1physical
10822173
LYN_HUMANLYNphysical
12882960
CD22_HUMANCD22physical
10748054
KPCD_HUMANPRKCDphysical
12024011
PTN11_HUMANPTPN11physical
9110989
SHC1_HUMANSHC1physical
8643691
BCR_HUMANBCRphysical
20304029
CLYBL_HUMANCLYBLphysical
20304029
CD2AP_HUMANCD2APphysical
22706086
CBL_HUMANCBLphysical
22706086
UBS3B_HUMANUBASH3Bphysical
22267732
NCK1_HUMANNCK1physical
22267732
KSYK_HUMANSYKphysical
22267732
PTN11_HUMANPTPN11physical
11157475
SH3K1_HUMANSH3KBP1physical
22815893
DAB1_HUMANDAB1physical
22815893
XIAP_HUMANXIAPphysical
22815893
K1H1_HUMANKRT31physical
25416956
KHDR3_HUMANKHDRBS3physical
25416956
K1C40_HUMANKRT40physical
25416956
KR107_HUMANKRTAP10-7physical
25416956
KR109_HUMANKRTAP10-9physical
25416956
KR103_HUMANKRTAP10-3physical
25416956
NT2NL_HUMANNOTCH2NLphysical
25416956

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SHIP1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-371, AND MASS SPECTROMETRY.
Phosphorylation
ReferencePubMed
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-865 AND TYR-1022, ANDMASS SPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-915, AND MASSSPECTROMETRY.

TOP